AnalystsFaisal Khurshid
Faisal Khurshid's Stock Forecasts

Analyst Ranking
Bottom 10%
#4389 out of 4867 analysts
Average Return
-20.95%
Win Rate
21%3 out of 14
Risk vs Reward
Poor
Good

Faisal Khurshid's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Trevi Therapeutics IncTRVI
+102.24%$3.12$6.31
2024-09-08 -
2025-04-29
Buy
Spyre Therapeutics IncSYRE
+27.29%$11.80$15.02
2025-04-07 -
2025-04-29
Buy
Ani Pharmaceuticals IncANIP
+19.59%$59.17$70.76
2024-12-10 -
2025-04-29
Buy

Faisal Khurshid Analyst Color

Get additional color on Faisal Khurshid's coverage of popular stocks

Faisal Khurshid's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ironwood Pharmaceuticals IncIRWD
2Hold$1.00+6.38%Maintains
16 days ago
Spyre Therapeutics IncSYRE
1Buy$45.00+199.60%Initiates Coverage On
23 days ago
Nurix Therapeutics IncNRIX
1Hold$16.00+39.86%Initiates Coverage On
a month ago
Shattuck Labs IncSTTK
1Buy$4.00+381.35%Initiates Coverage On
a month ago
Pliant Therapeutics IncPLRX
2Hold$2.00+35.14%Downgrades
2 months ago
Atyr Pharma IncATYR
1Buy$16.00+373.37%Initiates Coverage On
2 months ago
Kymera Therapeutics IncKYMR
2Buy$60.00+78.09%Maintains
4 months ago
Ani Pharmaceuticals IncANIP
1Buy$80.00+13.06%Initiates Coverage On
5 months ago
Zura Bio LtdZURA
1Buy$15.00+979.14%Initiates Coverage On
6 months ago
Trevi Therapeutics IncTRVI
1Buy$7.00+10.94%Assumes
8 months ago
Puretech Health PLCPRTC
1Buy$45.00+157.14%Assumes
8 months ago
Galapagos NvGLPG
1Hold$24.00-10.85%Initiates Coverage On
8 months ago
Geron CorpGERN
1Buy$7.00+407.25%Initiates Coverage On
8 months ago
Mannkind CorpMNKD
1Buy$8.00+62.93%Assumes
8 months ago
Immunic IncIMUX
1Buy$5.00+290.63%Assumes
8 months ago
Fusion Pharmaceuticals IncFUSN
1Hold$21.00N/ADowngrades
a year ago
Rain Oncology IncRAIN2
1Buy$11.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.